Conference abstractPublished 19 Oct 2017
Interchangeability of medicines using Metformin as a surrogate product (II)
University of Jos, Nigeria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Interchangeability of medicines, either over-the-counter or prescription drugs is a general and wide spread practice in health institutions. In our recent publication on interchangeability, it was discovered that cost, physical quality and full consent of the patient were employed in the substitution process. The current study was aimed at undertaking a bioequivalence Metformin hydrochloride tablets as a surrogate medicine for general interchangeability. USP methods were used for the quality assurance on the following parameters-uniformity of weight, hardness testing and identification, friability, disintegration and dissolution tests. The physicochemical evaluation of the samples showed compliance with USP specifications. All the formulations disintegrate within 15-30 minutes. Thirteen (13) brands complied with the monograph specifications (95-105%) for percent drug content, while four brands did not comply. Similarity factor (f2) value calculated for the brands were >50 indicating similarity with the innovator product hence can be interchanged except for the six brands (F, L, M, N, P and Q). Fifteen (15) of the seventeen (17) brands including the innovator brand passed the USP 32 general specifications standard for dissolution rate test for conventional release tablets. This study concludes that good pharmaceutical practice is required, so that a brand should pass percent drug content and dissolution tests and that those with f2 values >50 can safely be interchanged with the innovator product. Though cost and consent of the patient should be added advantage after selection based on bioequivalence studies.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jacob Adegboyega Kolawole”
- BylineArticles whose byline prints “Atibli Godwin”
- BylineArticles whose byline prints “Keturah Smith”
